Pelvic lymph node dissection in prostate cancer: current evidence, controversies, and future directions

Key Points

• The aim is to assess the role of pelvic lymph node dissection in the management of prostate cancer, focusing on current evidence and future implications.
• Reviewed contemporary evidence on ePLND in the context of prostate cancer management.
• Analyzed the impact of PSMA imaging on nodal staging and treatment outcomes.
• ePLND shows promise in enhancing oncologic outcomes for selected prostate cancer patients.
• Current evidence highlights ongoing controversies regarding the necessity and benefits of ePLND.

Abstract